AU2002239697A1 - Sodium hyaluronate microspheres - Google Patents

Sodium hyaluronate microspheres

Info

Publication number
AU2002239697A1
AU2002239697A1 AU2002239697A AU3969702A AU2002239697A1 AU 2002239697 A1 AU2002239697 A1 AU 2002239697A1 AU 2002239697 A AU2002239697 A AU 2002239697A AU 3969702 A AU3969702 A AU 3969702A AU 2002239697 A1 AU2002239697 A1 AU 2002239697A1
Authority
AU
Australia
Prior art keywords
sodium hyaluronate
hyaluronate microspheres
microspheres
sodium
hyaluronate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239697A
Inventor
Philip Dehazya
Cheng Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clear Solutions Biotech Inc
Original Assignee
Clear Solutions Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clear Solutions Biotech Inc filed Critical Clear Solutions Biotech Inc
Publication of AU2002239697A1 publication Critical patent/AU2002239697A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU2002239697A 2000-10-24 2001-10-24 Sodium hyaluronate microspheres Abandoned AU2002239697A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69544500A 2000-10-24 2000-10-24
US09695445 2000-10-24
PCT/US2001/050183 WO2002041877A1 (en) 2000-10-24 2001-10-24 Sodium hyaluronate microspheres

Publications (1)

Publication Number Publication Date
AU2002239697A1 true AU2002239697A1 (en) 2002-06-03

Family

ID=24792994

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239697A Abandoned AU2002239697A1 (en) 2000-10-24 2001-10-24 Sodium hyaluronate microspheres

Country Status (3)

Country Link
US (2) US20030096734A1 (en)
AU (1) AU2002239697A1 (en)
WO (1) WO2002041877A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425543B2 (en) * 1992-11-16 2008-09-16 The Corporation Of Mercer University Microencapsulated materials and method of making same
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
GB0129489D0 (en) * 2001-12-10 2002-01-30 Quadrant Healthcare Uk Ltd Sustained-release compositions
ITPD20020003A1 (en) * 2002-01-11 2003-07-11 Fidia Advanced Biopolymers Srl BIOMATERIALS BASED ON HYALURONIC ACID AS ANTI-ANGIOGENIC THERAPY IN CANCER TREATMENT.
CA2489712C (en) 2002-06-21 2016-07-12 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
GB2408207A (en) * 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
ITRM20040318A1 (en) * 2004-06-28 2004-09-28 Univ Palermo HYALURONIC AND ALPHA HYDROGEL, BETA-POLYASPARTYL HYDRAZIDE AND THEIR BIOMEDICAL AND PHARMACEUTICAL APPLICATIONS.
CN101217946B (en) * 2004-11-02 2012-11-07 特拉维夫大学未来技术研发有限公司 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their pharmaceutical use
WO2006113668A1 (en) * 2005-04-15 2006-10-26 University Of South Florida A method of transdermal drug delivery using hyaluronic acid nanoparticles
CA2623106C (en) 2005-09-19 2013-12-24 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
EP1991587B1 (en) * 2006-03-07 2013-07-24 ProChon Biotech Ltd. Hydrazido derivatives of hyaluronic acid
EP1992332A1 (en) * 2007-05-08 2008-11-19 Tupperware Products S.A. Cosmetic anti ageing skin care compositions
US20090035240A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
US20090035236A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
US9295621B2 (en) * 2007-07-31 2016-03-29 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant
US8344024B2 (en) * 2007-07-31 2013-01-01 Elc Management Llc Anhydrous cosmetic compositions containing resveratrol derivatives
US8080583B2 (en) 2007-07-31 2011-12-20 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
WO2009022340A1 (en) * 2007-08-15 2009-02-19 Metamorefix Peptides and pharmaceutical compositions for treating connective tissue
CN102617348B (en) * 2007-09-08 2016-05-18 Elc管理有限责任公司 Forulic acid resveratrol ester compounds, the compoistion and method of use that comprises this compound
EP2222715B1 (en) * 2007-12-19 2019-07-24 Evonik Degussa GmbH Crosslinked hyaluronic acid in emulsion
US20090285866A1 (en) * 2008-05-13 2009-11-19 Afriat Isabelle R Self-healing polymer compositions
US20100136070A1 (en) * 2008-12-03 2010-06-03 Jakk Group, Inc. Methods, devices, and compositions for dermal filling
US8263069B2 (en) 2008-12-31 2012-09-11 Johnson Lanny L Compositions including anthocyanin or anthocyanidin for the prevention or treatment of articular cartilage-associated conditions
US8197849B2 (en) * 2010-02-12 2012-06-12 National Health Research Institutes Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
US10865383B2 (en) 2011-07-12 2020-12-15 Lineage Cell Therapeutics, Inc. Methods and formulations for orthopedic cell therapy
CN103181902B (en) * 2011-12-30 2016-06-08 张文芳 A kind of gel micro-ball and quality control method thereof
FR2997406B1 (en) * 2012-10-25 2015-07-03 Basf Beauty Care Solutions F HYALURONATE AND GLUCOMANNAN POLYMER
CN103041448B (en) * 2013-01-17 2015-09-23 苏州博创同康生物工程有限公司 A kind of compound polysaccharide hemostatic material and its preparation method and application
US9968623B2 (en) 2013-08-29 2018-05-15 Lanny Leo Johnson Prepackaged sterile syringe or containers with various substance concentrations with or without bioactive reagent
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN108403644B (en) * 2018-03-16 2020-08-14 安徽工程大学 Anticancer medicine nano microsphere and its preparation method
IT201800008192A1 (en) * 2018-08-27 2020-02-27 Ira St Ricerche Applicate Spa MICROSPHERES OF HYALURONIC ACID CROSS-LINKED WITH UREA AND CONTAINING AT LEAST ONE ACTIVE AGENT OR DRUG
CN111686664B (en) * 2019-03-13 2022-10-28 杭州协合医疗用品有限公司 Emulsified cross-linked sodium hyaluronate gel microsphere for injection and preparation method thereof
CN111848991B (en) * 2020-07-21 2022-03-29 华熙生物科技股份有限公司 Preparation method of crosslinked hyaluronic acid microspheres
CN115918908A (en) * 2022-12-20 2023-04-07 济宁医学院附属医院 Quick-soluble sodium hyaluronate, preparation method, application and product

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1198449B (en) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani ESTERS OF POLYVALENT ALCOHOLS OF HYALURONIC ACID
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
GB2281861B (en) 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
US5766632A (en) * 1993-10-01 1998-06-16 Legere Pharmaceuticals, Ltd. Method of using lectins for contraception
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
US6071535A (en) * 1996-01-31 2000-06-06 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US5874105A (en) * 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
AUPO888097A0 (en) * 1997-08-29 1997-09-25 Biotech Australia Pty Limited Cross-linked particles
AU755465C (en) * 1998-06-01 2004-01-29 Fidia Farmaceutici S.P.A. Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants

Also Published As

Publication number Publication date
US20030096734A1 (en) 2003-05-22
US6969531B2 (en) 2005-11-29
WO2002041877A1 (en) 2002-05-30
US20040127459A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
AU2002239697A1 (en) Sodium hyaluronate microspheres
AU2001262237A1 (en) Reflector
EP1191039A4 (en) Polysaccharide derivative
AU4125001A (en) Computer case
AU2001293297A1 (en) Phyisological profiling
AU2001282481A1 (en) Articulated structure
EP1151667A3 (en) Plant-activating agent
AU7431901A (en) Coherence-free cache
AU2120200A (en) Cache memory
AU1554301A (en) Radioprotecting agent
AU2001241512A1 (en) Sulfonamide derivatives
AU2001296289A1 (en) Enhanced browsing environment
AU2001259272A1 (en) Viscometer
AU2000254982A1 (en) Instrumented stent
AU2001247447A1 (en) Mocvd-grown emode higfet buffer
EP1201403A3 (en) Electrofusible units
AU2002210369A1 (en) Processor bus arrangement
AU2001275516A1 (en) Sodium-free chondroitin
AU3586501A (en) Computer network
AU2001296039A1 (en) Computer
AU2001277461A1 (en) Hinge
AU2000261825A1 (en) Protruding structure block
AU3809500A (en) Expression
AU6759601A (en) Well
AU3816400A (en) Structure